Literature DB >> 23012690

Of heart and kidney: a complicated love story.

Dan Gaita1, Adelina Mihaescu2, Adalbert Schiller1.   

Abstract

The multiple connections that exist between the cardiovascular system and the kidney lead to a complex cardiovascular and renal medicine relationship. It is well established in the literature that chronic kidney disease (CKD) is an important and independent risk factor for cardiovascular disease (CVD). The prevalence of CKD in the general population is about 7%, comparable with the prevalence of diabetes. The main causes of CKD are diabetes and hypertension, worldwide. The prevalence of CVD in the CKD population ranges between 7 and 85% according to the CKD stage and type, and the patient diagnosed with CKD has a higher risk of dying of CVD than of starting renal replacement therapy. There are some particular aspects of CVD in CKD patients that differ from the general population, making its prevention and treatment a challenge for both cardiologists and nephrologists. © The European Society of Cardiology 2012.

Entities:  

Keywords:  Cardio-renal syndrome; cardiovascular prevention; cardiovascular risk; chronic kidney disease

Mesh:

Year:  2012        PMID: 23012690     DOI: 10.1177/2047487312462826

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  6 in total

1.  Trimethylamine-N-oxide acutely increases cardiac muscle contractility.

Authors:  Carlee I Oakley; Julian A Vallejo; Derek Wang; Mark A Gray; LeAnn M Tiede-Lewis; Tilitha Shawgo; Emmanuel Daon; George Zorn; Jason R Stubbs; Michael J Wacker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-04-03       Impact factor: 4.733

2.  Association of serum adiponectin concentration with aortic arterial stiffness in chronic kidney disease: from the KNOW-CKD study.

Authors:  Chang Seong Kim; Eun Hui Bae; Seong Kwon Ma; Sue K Park; Ju Yeon Lee; Wookyung Chung; Kyubeck Lee; Yeong Hoon Kim; Kook-Hwan Oh; Curie Ahn; Soo Wan Kim
Journal:  Clin Exp Nephrol       Date:  2016-08-11       Impact factor: 2.801

Review 3.  Preventive Aspects of Early Resveratrol Supplementation in Cardiovascular and Kidney Disease of Developmental Origins.

Authors:  Chien-Ning Hsu; Chih-Yao Hou; You-Lin Tain
Journal:  Int J Mol Sci       Date:  2021-04-19       Impact factor: 5.923

4.  Association between changes in the mRNA expression of platelet-activating factor receptor in peripheral blood mononuclear cells and progression of diabetic nephropathy.

Authors:  Sahar Ghavidel Darestani; Mihoko Kurano; Atsushi Shinnakasu; Kiyoaki Yamamoto; Yukari Dochi; Kayo Uemura; Yuko Ikeda; Aiko Arimura; Hiroshi Arimura; Akira Kikuchi; Hiroshi Hashiguchi; Takahisa Deguchi; Yoshihiko Nishio
Journal:  Diabetol Int       Date:  2019-04-11

5.  Vitamin D nutritional status and the risk for cardiovascular disease.

Authors:  Min Liu; Xianchi Li; Rongrong Sun; Y I Zeng; Shuang Chen; Peiying Zhang
Journal:  Exp Ther Med       Date:  2016-02-05       Impact factor: 2.447

Review 6.  Increased cardiovascular mortality associated with gout: a systematic review and meta-analysis.

Authors:  L E Clarson; P Chandratre; S L Hider; J Belcher; C Heneghan; E Roddy; C D Mallen
Journal:  Eur J Prev Cardiol       Date:  2013-11-26       Impact factor: 7.804

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.